Immunovant Inc (IMVT) USD0.0001

Sell:$14.17Buy:$14.22$0.09 (0.63%)

NASDAQ:0.09%
Prices delayed by at least 15 minutes
Sell:$14.17
Buy:$14.22
Change:$0.09 (0.63%)
Prices delayed by at least 15 minutes
Sell:$14.17
Buy:$14.22
Change:$0.09 (0.63%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 April 2025
Michael GeffnerChief Level Officer
Sell
Tax related
2,349$14.79$34,741.71225,370
23 April 2025
Jay S StoutCTO
Sell
Tax related
1,925$14.79$28,470.75209,243
16 April 2025
Peter (Pete) SalzmannCEO
Sell
Tax related
8,321$14.89$123,899.691,178,191
16 April 2025
Eva Renee BarnettCFO
Sell
Tax related
2,993$14.89$44,565.77396,774
9 April 2025
Peter (Pete) SalzmannCEO
Sell
Tax related
28,094$12.99$364,941.061,186,512
9 April 2025
Eva Renee BarnettCFO
Sell
Tax related
7,013$12.99$91,098.87403,817
9 April 2025
Eva Renee BarnettCFO
Sell
Tax related
4,050$12.99$52,609.50399,767
9 April 2025
Michael GeffnerChief Level Officer
Sell
Tax related
6,169$12.99$80,135.31227,719
9 April 2025
Jay S StoutCTO
Sell
Tax related
5,004$12.99$65,001.96211,168
7 March 2025
Andrew J (Drew) FromkinDirector
Sell
Tax related
6,616$19.52$129,144.3293,297

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
13 January 2025
ROIVANT SCIENCES LTDParent Company
Buy
Regular purchase transaction
16,845,010$20.00$336,900,200.0096,650,341
22 May 2024
Peter (Pete) SalzmannCEO
Sell
Tax related
16,163$29.65$479,232.951,036,716
21 August 2024
Peter (Pete) SalzmannCEO
Sell
Tax related
14,470$31.84$460,724.801,008,942
20 November 2024
Peter (Pete) SalzmannCEO
Sell
Tax related
16,692$25.45$424,811.40978,097
9 April 2025
Peter (Pete) SalzmannCEO
Sell
Tax related
28,094$12.99$364,941.061,186,512

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.